How a patient moves through a clinical trial [infographic]

Enrolling in a clinical trial is a big decision. It’s important to speak with friends, family members, health care providers, and other people living with your condition to make your decision about participation. But even then, the process can be a bit confusing.

Continue reading

What does study start up look like at clinical trial recruitment companies?

Getting a clinical trial started is often a collaborative effort between a number of different teams, from sponsors to sites to patient recruitment organizations. When it comes to clinical trial recruitment companies, what exactly does study start up look like? We spoke with Antidote’s Senior Manager of Strategic Client Services, Amrita Bhatt, about what it takes to kick off a new clinical trial ...

Continue reading

Webinar recap: Painting a portrait of the melanoma clinical trial participant

On June 24, Melanoma Research Alliance’s (MRA) Chief Science Officer Marc Hurlbert and Director of Communications Cody Barnett joined Antidote's Head of Partnerships Lindsey Wahlstrom-Edwards in a webinar to discuss what matters most to melanoma patients when it comes to participating in clinical trials. The conversation, informed by a 2018 study of 444 melanoma patients and survivors, provided ...

Continue reading

Bladder cancer clinical trial match and a Q&A with the Crush It For Curtis Foundation team

More than 80,000 people in the US will be diagnosed with bladder cancer this year. Treatment options have come a long way, and now include surgery, radiation, and chemotherapy — but many come with less than desirable side effects, and bladder cancer may recur. Research in this area is critical.

Continue reading

Virtual rare disease clinical trial recruitment: Q&A with Ben’s Friends and MyRareData

We recently announced a collaboration with Ben’s Friends, a network of online communities for people impacted by rare disease, and MyRareData, an organization that facilitates fundraising for advocacy groups through data, to bring information about clinical trials to the rare disease community.

Continue reading

Webinar recap: Changing the paradigm of patient centricity

With what we’re learning from the COVID-19 pandemic, can we create a permanent solution to keep the patient at the heart of clinical research? Last week a panel of experts, including our CEO, Laurent Schockmel, teamed up for an Ogilvy Consulting webinar, during which they discussed key industry considerations when it comes to putting patient centricity into action.

Continue reading

Biliary tract cancer research round-up

Biliary tract cancer (BTC) is a rare form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile to the small intestine. There are three types of biliary tract cancer: Intrahepatic cholangiocarcinoma (ICC, or bile duct cancer), extrahepatic cholangiocarcinoma, and gallbladder cancer. While this form of cancer is particularly tough ...

Continue reading

The evolving role of partnerships in clinical trial patient engagement

An interview with Lindsey Wahlstrom-Edwards, Head of Partnerships at Antidote

Continue reading

Painting a picture of the melanoma clinical trial participant

In 2018, Antidote worked with SCORR Marketing and eight leading health organizations, including the Melanoma Research Alliance (MRA), to survey 4,000 patients about clinical research. About 10% of the total respondents self-identified as having melanoma.

Continue reading

5 tips for loved ones supporting someone who lives with IBD

For people living with inflammatory bowel disease (IBD), the symptoms – diarrhea, bleeding ulcers, stomach pain, cramping, and weight loss – can be emotionally, mentally, and physically difficult. Knowing the right things to say (or not say) and do can help you have more empathetic and thoughtful conversations with loved ones who have IBD. Below are 5 tips for supporting someone who lives with ...

Continue reading

Get our latest posts in your inbox